New PET tracer may solve brain scan mystery after radiation
NCT ID NCT07511933
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests a new type of PET scan that uses a special tracer (Ga68-PSMA) to see if it can tell the difference between a growing tumor and radiation damage in people with brain metastases from lung cancer, melanoma, or breast cancer. About 100 adults who have had radiation therapy will get the scan. The goal is to help doctors make better treatment decisions without needing a biopsy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES FROM BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Netherlands Cancer Institute - Antoni van Leeuwenhoek
RECRUITINGAmsterdam, 1066 CX Amsterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mapping the hidden toll: how breast cancer brain metastases affect daily life
- Brain metastases trial tests skipping radiation when drugs work
- New combo attack on lung cancer brain metastases shows promise in Real-World study
- Brain tumor radiation gets a Same-Day Tune-Up
- New hope for breast cancer brain metastases: targeted drug Trop-2 ADC under study
- Brain tumor patients may avoid seizures with simple drug